213 filings
ARS
2023 FY
ZLAB
Zai Lab Limited
29 Apr 24
Annual report to shareholders
4:11pm
DEFA14A
ZLAB
Zai Lab Limited
29 Apr 24
Additional proxy soliciting materials
4:10pm
DEF 14A
ZLAB
Zai Lab Limited
Definitive proxy
29 Apr 24
4:09pm
S-3ASR
ZLAB
Zai Lab Limited
19 Apr 24
Automatic shelf registration
5:11pm
PRE 14A
ZLAB
Zai Lab Limited
Preliminary proxy
19 Apr 24
4:52pm
8-K
mf1679
27 Feb 24
Zai Lab Announces Full-Year 2023
4:12pm
8-K
ggbejaynxx1s
8 Feb 24
Entry into a Material Definitive Agreement
4:37pm
8-K
ejor8 9izk7ko4
7 Nov 23
Zai Lab Announces Third Quarter 2023
4:10pm
8-K
zftu11fz2p
7 Aug 23
Zai Lab Announces Second Quarter 2023
4:07pm
F-6EF
e2bxpwt48jc0xlv0f
14 Jul 23
Automatic registration for ADRs (foreign)
4:33pm
8-K
32i9q6
6 Jul 23
Zai Lab Announces Promotion of Yajing Chen to Chief Financial Officer
4:14pm
8-K
amm3lxmta9d9z
30 Jun 23
Zai Lab and argenx Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in China
4:18pm
8-K
211g9jksdqzbf8i cugb
20 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
80927h4 b7
6 Jun 23
Other Events
8:08am
8-K
j2n6l04g20cw qppt
9 May 23
Zai Lab Announces First Quarter 2023
4:03pm